Anixa Biosciences Inc Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Anixa Biosciences Inc quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q4 2019 to Q2 2024.
  • Anixa Biosciences Inc Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending July 31, 2024 was $87K, a 172% increase year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $87K +$55K +172% Jul 31, 2024 10-Q 2024-09-06
Q1 2024 $20K -$17K -45.9% Apr 30, 2024 10-Q 2024-06-04
Q4 2023 $24K -$18K -42.9% Jan 31, 2024 10-Q 2024-03-12
Q3 2023 $27K -$20K -42.6% Oct 31, 2023 10-K 2024-01-16
Q2 2023 $32K -$21K -39.6% Jul 31, 2023 10-Q 2023-09-06
Q1 2023 $37K -$22K -37.3% Apr 30, 2023 10-Q 2023-06-14
Q4 2022 $42K +$41.9K +63536% Jan 31, 2023 10-Q 2023-03-17
Q3 2022 $47K -$24.9K -34.7% Oct 31, 2022 10-K 2023-01-04
Q2 2022 $53K +$52.8K +28549% Jul 31, 2022 10-Q 2022-09-09
Q1 2022 $59K +$58.1K +6341% Apr 30, 2022 10-Q 2022-06-10
Q4 2021 $66.00 -$2.11K -97% Jan 31, 2022 10-Q 2022-03-11
Q3 2021 $71.9K +$68K +1727% Oct 31, 2021 10-K 2022-01-04
Q2 2021 $185 -$6.01K -97% Jul 31, 2021 10-Q 2021-09-01
Q1 2021 $916 -$7.98K -89.7% Apr 30, 2021 10-Q 2021-06-10
Q4 2020 $2.17K -$9.88K -82% Jan 31, 2021 10-Q 2021-03-11
Q3 2020 $3.94K Oct 31, 2020 10-K 2021-01-07
Q2 2020 $6.19K Jul 31, 2020 10-Q 2020-09-08
Q1 2020 $8.9K Apr 30, 2020 10-Q 2020-06-09
Q4 2019 $12.1K Jan 31, 2020 10-Q 2020-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.